Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing.

To investigate the genetic prognostic factors for the recurrence of non-muscle invasive bladder cancer.

The patients underwent transurethral resection of bladder tumor and received bacillus Calmette-Guérin (BCG) or epirubicin.